Anish Bhatnagar - 21 Jan 2022 Form 4 Insider Report for SOLENO THERAPEUTICS INC (SLNO)

Role
Chief Executive Officer
Signature
/s/ Anish Bhatnagar
Issuer symbol
SLNO
Transactions as of
21 Jan 2022
Transactions value $
-$14,559
Form type
4
Filing time
25 Jan 2022, 16:50:13 UTC
Next filing
01 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SLNO Common Stock Sale -$14,559 -39,033 -9.54% $0.373 370,227 21 Jan 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares that have been withheld by the Issuer to satisfy tax withholding and remittance obligations in connection with the vesting of restricted stock units.